{
  "trial_id": "NCT03219320",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, type 2 diabetes diagnosis, average pain intensity score, hemoglobin A1c (HbA1c) level, duration of diabetic peripheral neuropathy, body mass index (BMI), creatinine clearance, clinical laboratory values, psychiatric history, concomitant medication use, history of hypoglycemia or ketoacidosis, renal function, hepatic function, cardiovascular history, neurological history, infectious disease status, analgesic medication use, amputation status, suicidality assessment.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "DPN Disease History (years)",
          "duration of diabetic peripheral neuropathy"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "type 2 diabetes diagnosis",
        "average pain intensity score",
        "hemoglobin A1c (HbA1c) level",
        "body mass index (BMI)",
        "creatinine clearance",
        "clinical laboratory values",
        "psychiatric history",
        "concomitant medication use",
        "history of hypoglycemia or ketoacidosis",
        "renal function",
        "hepatic function",
        "cardiovascular history",
        "neurological history",
        "infectious disease status",
        "analgesic medication use",
        "amputation status",
        "suicidality assessment"
      ]
    },
    "processed-gen-response": "Age, gender, type 2 diabetes diagnosis, average pain intensity score, hemoglobin A1c (HbA1c) level, duration of diabetic peripheral neuropathy, body mass index (BMI), creatinine clearance, clinical laboratory values, psychiatric history, concomitant medication use, history of hypoglycemia or ketoacidosis, renal function, hepatic function, cardiovascular history, neurological history, infectious disease status, analgesic medication use, amputation status, suicidality assessment."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Duration of Diabetes, HbA1c, Body Mass Index, Creatinine Clearance, Baseline Pain Intensity, Use of Diabetic Medications, ",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "DPN Disease History (years)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Duration of Diabetes",
        "HbA1c",
        "Body Mass Index",
        "Creatinine Clearance",
        "Baseline Pain Intensity",
        "Use of Diabetic Medications"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Duration of Diabetes, HbA1c, Body Mass Index, Creatinine Clearance, Baseline Pain Intensity, Use of Diabetic Medications"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Diabetes Diagnosis Duration, HbA1c, Body Mass Index, Creatinine Clearance, Michigan Neuropathy Screening Instrument Score, Average Pain Intensity Score, Daily Pain Scores,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "DPN Disease History (years)",
          "Diabetes Diagnosis Duration"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "HbA1c",
        "Body Mass Index",
        "Creatinine Clearance",
        "Michigan Neuropathy Screening Instrument Score",
        "Average Pain Intensity Score",
        "Daily Pain Scores"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Diabetes Diagnosis Duration, HbA1c, Body Mass Index, Creatinine Clearance, Michigan Neuropathy Screening Instrument Score, Average Pain Intensity Score, Daily Pain Scores"
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index, hemoglobin A1c, duration of diabetic peripheral neuropathy, Michigan Neuropathy Screening Instrument score, calculated creatinine clearance, type of diabetic medications, duration of diabetic medications, presence of comorbidities, history of psychiatric disorders, presence of other painful conditions.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ],
        [
          "DPN Disease History (years)",
          "duration of diabetic peripheral neuropathy"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "body mass index",
        "hemoglobin A1c",
        "Michigan Neuropathy Screening Instrument score",
        "calculated creatinine clearance",
        "type of diabetic medications",
        "duration of diabetic medications",
        "presence of comorbidities",
        "history of psychiatric disorders",
        "presence of other painful conditions."
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, body mass index, hemoglobin A1c, duration of diabetic peripheral neuropathy, Michigan Neuropathy Screening Instrument score, calculated creatinine clearance, type of diabetic medications, duration of diabetic medications, presence of comorbidities, history of psychiatric disorders, presence of other painful conditions."
  }
}